申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20150344480A1
公开(公告)日:2015-12-03
The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.
本发明提供了式(I)化合物及其药学上可接受的盐。式(I)化合物能够抑制蛋白激酶活性,因此可用作抗癌剂。